Sex-specific differences at presentation and outcomes among patients undergoing transcatheter aortic valve replacement a cohort study

Annals of Internal Medicine

Volumn 164, Issue 6, 2016, Pages 377-384

  Kodali, Susheel ^a   Williams, Mathew R ^b   Doshi, Darshan ^a   Hahn, Rebecca T ^a   Humphries, Karin H ^c   Nkomo, Vuyisile T ^d   Cohen, David J ^e   Douglas, Pamela S ^f   Mack, Michael ^g   Xu, Ke ^h   Svensson, Lars ⁱ   Thourani, Vinod H ^j   Tuzcu, E Murat ⁱ   Weissman, Neil J ^k   Leon, Martin ^a   Kirtane, Ajay J ^a  

^a Department of Medicine   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d MAYO CLINIC   (United States)

^e SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^f DUKE UNIVERSITY MEDICAL CENTER   (United States)

^g SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^h CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

ⁱ LERNER RESEARCH INSTITUTE   (United States)

^j EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k MEDSTAR HEALTH RESEARCH INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART INFARCTION; HOSPITAL READMISSION; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; PARAVALVULAR LEAK; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL REPLACEMENT THERAPY; SECONDARY ANALYSIS; SEX DIFFERENCE; SMOKING; TRANSCATHETER AORTIC VALVE IMPLANTATION; ADVERSE EFFECTS; AGED; CAUSE OF DEATH; CLINICAL TRIAL; INCIDENCE; MORTALITY; MULTICENTER STUDY; POSTOPERATIVE HEMORRHAGE; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TREATMENT OUTCOME; VASCULAR DISEASES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CAUSE OF DEATH; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; MALE; PATIENT READMISSION; POSTOPERATIVE HEMORRHAGE; RISK FACTORS; SEX FACTORS; TRANSCATHETER AORTIC VALVE REPLACEMENT; TREATMENT OUTCOME; VASCULAR DISEASES;

EID: 84960880095     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M15-0121     Document Type: Article

References (44)

1. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H, et al; Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC). Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012; 33: 2451-96. [PMID: 22922415] doi: 10.1093/eurheartj/ehs109
2. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014; 63: 2438-88. [PMID: 24603192] doi: 10 .1016/j.jacc.2014.02.537
3. Connolly HM, Oh JK, Orszulak TA, Osborn SL, Roger VL, Hodge DO., et al. Aortic valve replacement for aortic stenosis with severe left ventricular dysfunction. Prognostic indicators. Circulation. 1997; 95: 2395-400. [PMID: 9170402]
4. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al; PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010; 363: 1597-607. [PMID: 20961243] doi: 10.1056/ NEJMoa1008232
5. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al; PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011; 364: 2187-98. [PMID: 21639811] doi: 10.1056/NEJMoa1103510
6. Makkar RR, Fontana GP, Jilaihawi H, Kapadia S, Pichard AD, Douglas PS, et al; PARTNER Trial Investigators. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med. 2012; 366: 1696-704. [PMID: 22443478] doi: 10.1056/NEJMoa1202277
7. Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, et al; PARTNER Trial Investigators. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012; 366: 1686-95. [PMID: 22443479] doi: 10.1056/NEJMoa1200384
8. Kapadia SR, Leon MB, Makkar RR, Tuzcu EM, Svensson LG, Kodali S, et al; PARTNER trial investigators. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015; 385: 2485-91. [PMID: 25788231] doi: 10 .1016/S0140-6736(15)60290-2
9. Mack MJ, Leon MB, Smith CR, Miller DC, Moses JW, Tuzcu EM, et al; PARTNER 1 trial investigators. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015; 385: 2477-84. [PMID: 25788234] doi: 10.1016/S0140-6736(15)60308-7
10. Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, et al; U.S. CoreValve Clinical Investigators. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014; 370: 1790-8. [PMID: 24678937] doi: 10.1056/NEJMoa1400590
11. Popma JJ, Adams DH, Reardon MJ, Yakubov SJ, Kleiman NS, Heimansohn D, et al; CoreValve United States Clinical Investigators. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol. 2014; 63: 1972-81. [PMID: 24657695] doi: 10.1016/j.jacc.2014.02.556
12. Mack MJ, Brennan JM, Brindis R, Carroll J, Edwards F, Grover F, et al; STS/ACC TVT Registry. Outcomes following transcatheter aortic valve replacement in the United States. JAMA. 2013; 310: 2069-77. [PMID: 24240934] doi: 10.1001/jama.2013.282043
13. O'Brien SM, Shahian DM, Filardo G, Ferraris VA, Haan CK, Rich JB, et al; Society of Thoracic Surgeons Quality Measurement Task Force. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2-isolated valve surgery. Ann Thorac Surg. 2009; 88: S23-42. [PMID: 19559823] doi: 10.1016/j.athoracsur.2009.05.056
14. Fuchs C, Mascherbauer J, Rosenhek R, Pernicka E, Klaar U, Scholten C., et al. Gender differences in clinical presentation and surgical outcome of aortic stenosis. Heart. 2010; 96: 539-45. [PMID: 20350991] doi: 10.1136/hrt.2009.186650
15. Duncan AI, Lin J, Koch CG, Gillinov AM, Xu M, Starr NJ. The impact of gender on in-hospital mortality and morbidity after isolated aortic valve replacement. Anesth Analg. 2006; 103: 800-8. [PMID: 17000785]
16. Klodas E, Enriquez-Sarano M, Tajik AJ, Mullany CJ, Bailey KR, Seward JB. Surgery for aortic regurgitation in women. Contrasting indications and outcomes compared with men. Circulation. 1996; 94: 2472-8. [PMID: 8921790]
17. Onorati F, D'Errigo P, Barbanti M, Rosato S, Covello RD, Maraschini A, et al; OBSERVANT Research Group. Different impact of sex on baseline characteristics and major periprocedural outcomes of transcatheter and surgical aortic valve interventions: results of the multicenter Italian OBSERVANT Registry. J Thorac Cardiovasc Surg. 2014; 147: 1529-39. [PMID: 23856202] doi: 10.1016/j.jtcvs.2013.05 .039
18. Buja P, Napodano M, Tamburino C, Petronio AS, Ettori F, Santoro G, et al; Italian Multicenter CoreValve Registry Investigators. Comparison of variables in men versus women undergoing transcatheter aortic valve implantation for severe aortic stenosis (from Italian Multicenter CoreValve registry). Am J Cardiol. 2013; 111: 88-93. [PMID: 23245837] doi: 10.1016/j.amjcard.2012.08.051
19. Hayashida K, Morice MC, Chevalier B, Hovasse T, Romano M, Garot P., et al. Sex-related differences in clinical presentation and outcome of transcatheter aortic valve implantation for severe aortic stenosis. J Am Coll Cardiol. 2012; 59: 566-71. [PMID: 22300690] doi: 10.1016/j.jacc.2011.10.877
20. Humphries KH, Toggweiler S, Rodés-Cabau J, Nombela-Franco L, Dumont E, Wood DA., et al. Sex differences in mortality after transcatheter aortic valve replacement for severe aortic stenosis. J Am Coll Cardiol. 2012; 60: 882-6. [PMID: 22818068] doi: 10.1016/j.jacc .2012.05.009
21. Zahn R, Gerckens U, Linke A, Sievert H, Kahlert P, Hambrecht R, et al; German Transcatheter Aortic Valve Interventions-Registry Investigators. Predictors of one-year mortality after transcatheter aortic valve implantation for severe symptomatic aortic stenosis. Am J Cardiol. 2013; 112: 272-9. [PMID: 23578349] doi: 10.1016/j.amjcard.2013 .03.024
22. Williams M, Kodali SK, Hahn RT, Humphries KH, Nkomo VT, Cohen DJ., et al. Sex-related differences in outcomes after transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis: insights from the PARTNER Trial (Placement of Aortic Transcatheter Valve). J Am Coll Cardiol. 2014; 63: 1522-8. [PMID: 24561149] doi: 10.1016/j.jacc.2014.01.036
23. Sherif MA, Zahn R, Gerckens U, Sievert H, Eggebrecht H, Hambrecht R., et al. Effect of gender differences on 1-year mortality after transcatheter aortic valve implantation for severe aortic stenosis: results from a multicenter real-world registry. Clin Res Cardiol. 2014; 103: 613-20. [PMID: 24599329] doi: 10.1007/s00392-014-0690-6
24. Buchanan GL, Chieffo A, Montorfano M, Maisano F, Latib A, Godino C., et al. The role of sex on VARC outcomes following transcatheter aortic valve implantation with both Edwards SAPIEN? and Medtronic CoreValve ReValving System? devices: the Milan registry. EuroIntervention. 2011; 7: 556-63. [PMID: 21930459] doi: 10 .4244/EIJV7I5A91
25. Van Mieghem NM, Tchetche D, Chieffo A, Dumonteil N, Messika-Zeitoun D, Van Der Boon RM., et al. Incidence, predictors, and implications of access site complications with transfemoral transcatheter aortic valve implantation. Am J Cardiol. 2012; 110: 1361-7. [PMID: 22819428] doi: 10.1016/j.amjcard.2012.06.042
26. Houthuizen P, Van Garsse LA, Poels TT, De Jaegere P, Van Der Boon RM, Swinkels BM., et al. Left bundle-branch block induced by transcatheter aortic valve implantation increases risk of death. Circulation. 2012; 126: 720-8. [PMID: 22791865] doi: 10.1161/CIRCULATIONAHA.112.101055
27. Diemert P, Seiffert M, Schnabel R, Wilde S, Conradi L, Schirmer J., et al. Patient gender does not affect outcome after transcatheter aortic valve implantation (TAVI). J Heart Valve Dis. 2013; 22: 789-93. [PMID: 24597399]
28. Conrotto F, D'Ascenzo F, Salizzoni S, Presbitero P, Agostoni P, Tamburino C., et al. A gender based analysis of predictors of all cause death after transcatheter aortic valve implantation. Am J Cardiol. 2014; 114: 1269-74. [PMID: 25159239] doi: 10.1016/j.amjcard .2014.07.053
29. Douglas PS, Waugh RA, Bloomfield G, Dunn G, Davis L, Hahn RT., et al. Implementation of echocardiography core laboratory best practices: a case study of the PARTNER I trial. J Am Soc Echocardiogr. 2013; 26: 348-358.e3. [PMID: 23465887] doi: 10.1016/j.echo .2013.01.013
30. Roques F, Michel P, Goldstone AR, Nashef SA. The logistic EuroSCORE [Letter]. Eur Heart J. 2003; 24: 881-2. [PMID: 12727160]
31. Chieffo A, Hoye A, Mauri F, Mikhail GW, Ammerer M, Grines C, et al; WIN Group. Gender-based issues in interventional cardiology: a consensus statement from the Women in Innovations (WIN) initiative. EuroIntervention. 2010; 5: 773-9. [PMID: 20142190]
32. Généreux P, Webb JG, Svensson LG, Kodali SK, Satler LF, Fearon WF, et al; PARTNER Trial Investigators. Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial. J Am Coll Cardiol. 2012; 60: 1043-52. [PMID: 22883632] doi: 10.1016/j.jacc.2012 .07.003
33. Tchetche D, Van Der Boon RM, Dumonteil N, Chieffo A, Van Mieghem NM, Farah B., et al. Adverse impact of bleeding and transfusion on the outcome post-transcatheter aortic valve implantation: insights from the Pooled-RotterdAm-Milano-Toulouse In Collaboration Plus (PRAGMATIC Plus) initiative. Am Heart J. 2012; 164: 402-9. [PMID: 22980308] doi: 10.1016/j.ahj.2012.07.003
34. Ndrepepa G, Schulz S, Neumann FJ, Byrne RA, Hoppmann P, Cassese S., et al. Bleeding after percutaneous coronary intervention in women and men matched for age, body mass index, and type of antithrombotic therapy. Am Heart J. 2013; 166: 534-40. [PMID: 24016504] doi: 10.1016/j.ahj.2013.07.006
35. Cohen M, Dawson MS, Kopistansky C, McBride R. Sex and other predictors of intra-Aortic balloon counterpulsation-related complications: prospective study of 1119 consecutive patients. Am Heart J. 2000; 139: 282-7. [PMID: 10650301]
36. Argulian E, Patel AD, Abramson JL, Kulkarni A, Champney K, Palmer S., et al. Gender differences in short-term cardiovascular outcomes after percutaneous coronary interventions. Am J Cardiol. 2006; 98: 48-53. [PMID: 16784919]
37. Applegate RJ, Sacrinty MT, Kutcher MA, Baki TT, Gandhi SK, Kahl FR., et al. Vascular complications in women after catheterization and percutaneous coronary intervention 1998-2005. J Invasive Cardiol. 2007; 19: 369-74. [PMID: 17827504]
38. Ahmed B, Piper WD, Malenka D, VerLee P, Robb J, Ryan T., et al. Significantly improved vascular complications among women undergoing percutaneous coronary intervention: a report from the Northern New England Percutaneous Coronary Intervention Registry. Circ Cardiovasc Interv. 2009; 2: 423-9. [PMID: 20031752] doi: 10 .1161/CIRCINTERVENTIONS.109.860494
39. Schwertz DW, Penckofer S. Sex differences and the effects of sex hormones on hemostasis and vascular reactivity. Heart Lung. 2001; 30: 401-26. [PMID: 11723446]
40. Ahmed B, Lischke S, Holterman LA, Straight F, Dauerman HL. Angiographic predictors of vascular complications among women undergoing cardiac catheterization and intervention. J Invasive Cardiol. 2010; 22: 512-6. [PMID: 21041845]
41. Carroll JD, Carroll EP, Feldman T, Ward DM, Lang RM, Mc- Gaughey D., et al. Sex-Associated differences in left ventricular function in aortic stenosis of the elderly. Circulation. 1992; 86: 1099-107. [PMID: 1394918]
42. Petrov G, Regitz-Zagrosek V, Lehmkuhl E, Krabatsch T, Dunkel A, Dandel M., et al. Regression of myocardial hypertrophy after aortic valve replacement: faster in women?. Circulation. 2010; 122: S23-8. [PMID: 20837918] doi: 10.1161/CIRCULATIONAHA.109.927764
43. Villari B, Campbell SE, Schneider J, Vassalli G, Chiariello M, Hess OM. Sex-dependent differences in left ventricular function and structure in chronic pressure overload. Eur Heart J. 1995; 16: 1410-9. [PMID: 8746910]
44. Kodali S, Pibarot P, Douglas PS, Williams M, Xu K, Thourani V., et al. Paravalvular regurgitation after transcatheter aortic valve replacement with the Edwards SAPIEN valve in the PARTNER trial: characterizing patients and impact on outcomes. Eur Heart J. 2015; 36: 449-56. [PMID: 25273886] doi: 10.1093/eurheartj/ehu384